CINECA IRIS Institutional Research Information System

LENCIONI, RICCARDO ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.721
AS - Asia 10.213
EU - Europa 7.796
SA - Sud America 1.448
AF - Africa 196
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 11
Totale 40.407
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.081
SG - Singapore 2.921
CN - Cina 2.888
IT - Italia 2.089
HK - Hong Kong 1.984
BR - Brasile 1.216
SE - Svezia 1.067
GB - Regno Unito 1.061
DE - Germania 863
VN - Vietnam 803
BG - Bulgaria 757
CA - Canada 516
TR - Turchia 515
UA - Ucraina 460
FR - Francia 355
FI - Finlandia 352
RU - Federazione Russa 343
KR - Corea 318
JP - Giappone 160
CH - Svizzera 157
IN - India 155
BD - Bangladesh 76
AR - Argentina 74
MX - Messico 70
IQ - Iraq 61
NL - Olanda 57
AT - Austria 54
ID - Indonesia 50
EC - Ecuador 39
PK - Pakistan 39
VE - Venezuela 36
BE - Belgio 35
SA - Arabia Saudita 35
ZA - Sudafrica 31
CI - Costa d'Avorio 30
PL - Polonia 28
UZ - Uzbekistan 28
ES - Italia 26
PY - Paraguay 24
CO - Colombia 23
AU - Australia 20
MA - Marocco 20
MY - Malesia 18
BJ - Benin 17
EG - Egitto 16
JO - Giordania 16
NG - Nigeria 16
PH - Filippine 16
PT - Portogallo 15
SN - Senegal 15
CL - Cile 14
IE - Irlanda 14
KZ - Kazakistan 14
NP - Nepal 14
DZ - Algeria 13
AE - Emirati Arabi Uniti 11
TW - Taiwan 11
KE - Kenya 10
CZ - Repubblica Ceca 9
UY - Uruguay 9
JM - Giamaica 8
LT - Lituania 8
PE - Perù 8
BB - Barbados 7
IL - Israele 7
KG - Kirghizistan 7
OM - Oman 7
PS - Palestinian Territory 7
TH - Thailandia 7
TN - Tunisia 7
AM - Armenia 6
CR - Costa Rica 6
EU - Europa 6
IR - Iran 6
PA - Panama 6
TT - Trinidad e Tobago 6
AL - Albania 5
AZ - Azerbaigian 5
HU - Ungheria 5
LB - Libano 5
RO - Romania 5
BY - Bielorussia 4
CY - Cipro 4
HN - Honduras 4
MD - Moldavia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BH - Bahrain 3
BN - Brunei Darussalam 3
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
KW - Kuwait 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BT - Bhutan 2
CG - Congo 2
Totale 40.357
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.191
Ashburn 2.017
Hong Kong 1.952
Fairfield 1.890
Singapore 1.575
Houston 1.515
Ann Arbor 1.500
Santa Clara 1.085
Chandler 963
San Jose 870
Seattle 782
Sofia 756
Lancaster 747
Cambridge 644
Dallas 636
Wilmington 636
Shanghai 592
Milan 581
Jacksonville 571
Beijing 559
New York 493
Ottawa 454
Serra 411
Izmir 335
Boardman 322
Hefei 318
Princeton 310
Seoul 300
Lawrence 290
Nanjing 265
Lauterbourg 251
Medford 238
Los Angeles 219
Ho Chi Minh City 202
Des Moines 160
Bern 153
Tokyo 140
Dearborn 139
Istanbul 138
Hanoi 131
Frankfurt am Main 129
Nanchang 118
Buffalo 105
Redondo Beach 100
Jüchen 97
San Diego 88
São Paulo 85
Dong Ket 73
Boulder 65
Pisa 65
Grafing 64
Munich 61
Council Bluffs 60
Redwood City 59
Helsinki 58
Kunming 53
Shenyang 53
Changsha 52
Düsseldorf 51
Falls Church 51
Chicago 47
Florence 47
Rome 47
Ogden 46
Vienna 45
Hebei 44
Columbus 41
Guangzhou 40
The Dalles 39
Orem 38
Rio de Janeiro 35
Tianjin 35
London 34
Pune 33
Hangzhou 31
Abidjan 30
Jiaxing 30
Brussels 29
Da Nang 28
Orange 27
Tashkent 27
Belo Horizonte 26
Norwalk 25
Nuremberg 25
Turku 24
Washington 24
Campinas 23
Warsaw 21
Baghdad 20
Dhaka 20
Haiphong 20
Curitiba 19
Detroit 19
Fuzhou 19
Auburn Hills 18
Salvador 18
Zhengzhou 18
Altopascio 17
Chennai 17
Cotonou 17
Totale 29.981
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of combination therapy with everolimus and sorafenib for recurrence of hepatocellular carcinoma after liver transplantation. 232
Percutaneous radiofrequency ablation (pRTA) of pulmonary tumors 215
Society of Interventional Radiology Interventional Oncology Task Force: interventional oncology research vision statement and critical assessment of the state of research affairs 214
Cost-effectiveness of intrainstitutional information exchange in the diagnostic and therapeutic management of hepatocellular carcinoma 210
How to report and compare complications of image-guided ablation therapies: comments on seeding and the use of a sole common denominator for liver tumors 208
COMPUTED TOMOGRAPHY OF HEPATOCELLULAR CARCINOMA 207
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma 204
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization 202
Assessment of hyperemia in acute appendicitis: Comparison between power Doppler and color Doppler sonography 200
Electrodes and multiple electrode systems for radiofrequency ablation: a proposal for updated terminology 198
Breath-hold spin-echo MR imaging for evaluation of dynamic enhancement of native and treated hepatocellular carcinoma after intravenous Gd-DTPA administration 197
Multiple osteomata from medieval Tuscany, Italy (ca. 10th–12th AD) 197
New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice 194
Abdominal aortic aneurysms: efficacy of sonography for preoperative assessment 193
TERMOABLAZIONE DI NEOPLASIE POLMONARI MALIGNE: QUALI PROSPETTIVE 193
Colorectal cancer: role of CT colonography in preoperative evaluation after incomplete colonoscopy 190
What is the long-term survival benefit of radiofrequency ablation in patients with colorectal liver metastases? 187
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations 187
Transmission of radiological images using broadband communications 186
FOCAL LIVER LESIONS: DETECTION, CHARACTERIZATION, ABLATION 186
Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical Recommendations 185
Cavernous arterial and arteriolar circulation in patients with erectile dysfunction: a power Doppler study 181
European Guidelines in LIver Contrast Ultrasound 181
Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media 181
Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) guidelines on the use of contrast agents in liver ultrasound 180
Image-guided ablation for hepatocellular carcinoma 180
RADIOFREQUENCY THERMAL ABLATION OF HEPATOCELLULAR CARCINOMA 180
Differentiation of hepatocellular adenoma and focal nodular hyperplasia of the liver: comparison of power Doppler imaging and conventional color Doppler sonography 179
Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization 179
Hepatocellular carcinoma 179
Percutaneous methods for ablation of hepatic neoplasms 177
Abdominal MR: liver and pancreas 177
A New SteatoScore in the Evaluation of Non-Alcoholic Liver Disease in Oncologic Patients 174
Ethanol injection for the treatment of hepatic tumours 174
Chemoembolization for hepatocellular carcinoma 174
HEPATIC ADENOMA AND FOCAL NODULAR HYPERPLASIA - DIFFERENTIATION WITH USE OF POWER DOPPLER US 173
Benign regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation 173
US image acquisition 173
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report 173
Cancer and therapy in the 16th century: the unique case of adenocarcinoma in Luigi Carafa, prince of Stigliano (1511–76) 173
Magnetic Resonance Imaging in Liver Disease Technical Approach, Diagnostic Imaging of Liver Neoplasms, Focus on a New Superparamagnetic Contrast Agent 171
INTRAOPERATIVE RADIOFREQUENCY THERMAL ABLATION: A NEW APPROACH TO THE TREATMENT OF THE HEPATIC FOCAL LESIONS 170
IMAGING EVALUATION OF TUMOR RESPONSE 170
Ethanol ablation of hepatocellular carcinoma Up to 5.0 cm by using a multipronged injection needle with high-dose strategy 170
European federation of societies for ultrasound in medicine and biology (EFSUMB) guidelines for the use of contrast agents in liver ultrasound: what is the impact in clinical practice? 169
PANCREAS TRANSPLANTATION 169
Surveillance and early diagnosis of hepatocellular carcinoma 169
A preliminary study on radiofrequency thermal ablation of lung tumors 168
Guidance and assessment of interventional theraphy in liver 168
Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma 168
Prediction of pathological tumor volume in clinically localized prostate cancer: value of endorectal coil magnetic resonance imaging 167
Local staging of prostate carcinoma with endorectal coil MRI: correlation with whole-mount radical prostatectomy specimens 167
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma 167
Combined treatment of large hepatocellular carcinoma with transcatheter arterial chemoembolization and percutaneous ethanol injection with a multipronged needle: experimental and clinical investigation 167
Usefulness of echo-color Doppler in differentiating parathyroid lesions from other cervical masses 167
Is the treatment of hepatocellular carcinoma on the waiting list necessary? 166
Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma 166
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008 166
Pulmonary radiofrequency ablation in a single lung patient 165
Percutaneous ethanol injection for hepatocellular carcinoma: alive or dead? 164
Radiofrequency ablation of liver tumors: assessment of treatment outcome with diffusion weighted MR imaging 164
Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study) 163
PERCUTANEOUS ETHANOL INJECTION OF HEPATOCELLULAR CARCINOMA AND BORDERLINE LESIONS 162
Delta-radiomics in cancer immunotherapy response prediction: a systematic review 161
Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion 161
Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation 160
Guidelines for the use of contrast agents in ultrasound. January 2004. 159
Treatment before liver transplantation for HCC 158
Endorectal magnetic resonance imaging in local staging of prostate carcinoma 158
MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis 158
Comparison among sonography, double-tracer subtraction scintigraphy, and double-phase scintigraphy in the detection of parathyroid lesions 158
HEPATOCELLULAR CARCINOMA: CT AND MR FEATURES AFTER TRANSCATHETER ARTERIAL EMBOLIZATION AND PERCUTANEOUS ETHANOL INJECTION 157
HEPATOCELLULAR CARCINOMA TREATMENT WITH PERCUTANEOUS ETHANOL INJECTION: EVALUATION WITH CONTRAST-ENHANCED COLOR DOPPLER US 157
Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection 157
Colorectal liver metastases: ADC as an imaging biomarker of tumor behavior and therapeutic response 157
Dark-PAP sign: a new prognostic marker in patients with preserved left ventricular ejection fraction 156
Using Internet in a clinical trial: a preliminary experience 156
Design and rationale for the non-interventional Global Investigation of Therapeutic DEcisions in Hepatocellular Carcinoma and Of its Treatment with Sorafenib (GIDEON) study 155
Novel Transarterial Biomimetic-Based Nanoparticles for the Treatment of Hepatocellular Carcinoma 155
Combined therapies 154
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma 154
Fatal thrombosis of the portal vein following single-session percutaneous ethanol injection therapy of hepatocellular carcinoma 153
MR virtual endoscopy of the pancreaticobiliary tract: a feasible technique? 153
Electrodes and multiple electrode systems for radio frequency ablation: a proposal for updated terminology 153
Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? 149
Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study 149
Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study 149
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 148
Radiofrequency ablation of pulmonary malignancies: value of multiplanar ct imaging for optimizing treatment protocol 148
Radiofrequency thermal ablation versus percutaneous ethanol injection for small hepatocellular carcinoma 148
Focal Liver Lesions 148
Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective 148
Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors 147
TUMOR VOLUME DETERMINED WITH ENDORECTAL COIL MRI AS A PREDICTOR OF THE LOCAL STAGE OF PROSTATE CARCINOMA 146
First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study 146
Percutaneous radiofrequency ablation of primary NSCLC 145
Percutaneous injection of ethanol to treat autonomous thyroid nodules 145
Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US 144
Endorectal coil MR imaging findings in hemospermia 144
Local-regional treatment of hepatocellular carcinoma 144
Totale 17.027
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021463 0 0 0 0 0 0 0 0 0 0 115 348
2021/20223.139 70 185 61 238 583 503 58 170 116 100 223 832
2022/20232.712 413 225 164 247 349 411 33 217 451 16 152 34
2023/20242.650 384 290 358 164 396 586 58 39 46 34 37 258
2024/20258.080 23 321 59 384 741 814 621 534 892 1.169 837 1.685
2025/20267.722 436 1.125 881 697 672 905 1.266 485 461 764 30 0
Totale 40.681